Total Funding
80
17
Total FundingVenture - Series Unknown raised
Growth Score 80 in past quarter
-6 pts
Heat Score 17 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3165577
DIRAmed is developing pain-free, non-invasive meters that accurately measure the levels of key constituents of the human body such as
- Robert Schlegel: CEO
About the Company
DIRAmed is developing pain-free, non-invasive meters that accurately measure the levels of key constituents of the human body such as glucose, ketones, cholesterol, and therapeutic drugs. DIRAmed's meters will significantly improve the process by which diabetics and other patients taking therapeutic drugs monitor the levels of important
components in their blood and tissue. DIRAmed currently has investigational prototypes in clinical studies for use in improving tight glycemic control in hospital critical care continuous glucose monitoring applications. DIRAmed is also discussing other designs with selected strategic partners including the development of mobile units for personal use with or without connection to an insulin pump.
